EVENTIDE ASSET MANAGEMENT, LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1442891 Boston, MA

Position in AXSM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$77,548,031

-$10,267,662 QoQ

Shares Held

316,820

-39.0% QoQ

Ownership

0.605%

of shares outstanding

% of Portfolio

1.04%

of 13F equity value

Holder Rank

#31

of 494 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EVENTIDE ASSET MANAGEMENT, LLC holds $1,774,593,873 across 55 Biotechnology names. AXSM ranks #5 (4.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MIRM	Mirum Pharmaceuticals, Inc.	1,248,389	$146,148,900
2	ARGX	Argenx SE	125,668	$116,591,000
3	SRRK	Scholar Rock Holding Corp	2,111,410	$116,127,550
4	PCVX	Vaxcyte, Inc.	1,380,219	$80,232,130
5	AXSM	Axsome Therapeutics, Inc. This page	316,820	$77,548,031
6	RPRX	Royalty Pharma plc	1,380,261	$77,391,234
7	INSM	INSMED Inc	583,665	$62,230,362
8	BLTE	Belite Bio, Inc	390,829	$60,181,803

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$77,548,031	316,820	-39.0%	Shares	Sole	2026-08-14
2026-03-31	$87,815,693	519,558	-9.0%	Shares	Sole	2026-05-15
2025-12-31	$104,328,716	571,226	-23.5%	Shares	Sole	2026-02-13
2025-09-30	$90,650,037	746,398	+2.9%	Shares	Sole	2025-11-14
2025-06-30	$75,752,900	725,672	-2.6%	Shares	Sole	2025-08-14
2025-03-31	$86,871,855	744,850	-10.1%	Shares	Sole	2025-05-15
2024-12-31	$70,117,237	828,711	+0.1%	Shares	Sole	2025-02-14
2024-09-30	$74,402,204	827,887	-11.8%	Shares	Sole	2024-11-14
2024-06-30	$75,566,477	938,714	+170.7%	Shares	Sole	2024-08-13
2024-03-31	$27,667,617	346,712	0.0%	Shares	Sole	2024-05-15
2023-12-31	$27,594,808	346,712	0.0%	Shares	Sole	2024-02-20
2023-09-30	$24,231,701	346,712	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.